| scholarly article | Q13442814 |
| P2093 | author name string | Pedro A Jose | |
| Regina M Day | |||
| Robert J Lechleider | |||
| Shiyou Chen | |||
| Jennifer E Leader | |||
| Michelle Crawford | |||
| Victorino R Briones | |||
| P2860 | cites work | Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism | Q24600173 |
| PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate | Q24683266 | ||
| The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation | Q28207920 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons | Q28587133 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Transcriptional control by the TGF-beta/Smad signaling system | Q29618985 | ||
| Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization | Q30306237 | ||
| L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. | Q30433980 | ||
| Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. | Q33334687 | ||
| Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall | Q33537227 | ||
| Specificity, diversity, and regulation in TGF-beta superfamily signaling. | Q33792305 | ||
| Role of Ras and Mapks in TGFbeta signaling | Q33857574 | ||
| Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA | Q34011759 | ||
| Molecular control of neural crest formation, migration and differentiation | Q34076847 | ||
| Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta | Q34771801 | ||
| Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). | Q35846514 | ||
| Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42. | Q38342615 | ||
| Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation. | Q38343583 | ||
| Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. | Q40404500 | ||
| Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo | Q40497387 | ||
| Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism | Q40527668 | ||
| RhoA and Rac1 are both required for efficient wound closure of airway epithelial cells | Q40527674 | ||
| Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line | Q40570886 | ||
| HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells. | Q40875479 | ||
| In vitro system for differentiating pluripotent neural crest cells into smooth muscle cells | Q41052260 | ||
| Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases | Q42802765 | ||
| Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. | Q44567721 | ||
| Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin | Q45009104 | ||
| Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies | Q45028368 | ||
| Contractile properties of the cultured vascular smooth muscle cells: the crucial role played by RhoA in the regulation of contractility | Q46387635 | ||
| A Role for Rho in Smooth Muscle Phenotypic Regulation | Q57702970 | ||
| Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells | Q69618965 | ||
| Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity | Q77469542 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1765-1770 | |
| P577 | publication date | 2005-11-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation | |
| P478 | volume | 281 |
| Q89565682 | A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts |
| Q36593235 | A novel in vitro model system for smooth muscle differentiation from human embryonic stem cell-derived mesenchymal cells |
| Q35456617 | Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy |
| Q34221060 | Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension |
| Q37924871 | Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle |
| Q42613297 | Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels |
| Q37679826 | Divergent signaling pathways cooperatively regulate TGFβ induction of cysteine-rich protein 2 in vascular smooth muscle cells |
| Q34911096 | E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. |
| Q33607369 | Effect of cAMP on TGFbeta1-induced corneal keratocyte-myofibroblast transformation |
| Q34889421 | Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. |
| Q28510584 | Endoglin is required for myogenic differentiation potential of neural crest stem cells |
| Q48299478 | Expression of smooth muscle cell-specific proteins in neural progenitor cells induced by agonists of G protein-coupled receptors and transforming growth factor-beta |
| Q92581183 | Gelatin microspheres releasing transforming growth factor drive in vitro chondrogenesis of human periosteum derived cells in micromass culture |
| Q40539463 | Gene expression profile in the activation of subperitoneal fibroblasts reflects prognosis of patients with colon cancer |
| Q34801048 | HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury |
| Q37419031 | Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome. |
| Q90363529 | Haploinsufficient Rock1+/- and Rock2+/- Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis |
| Q30424133 | Histone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells |
| Q36232124 | Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit |
| Q52589939 | Hypoxia Supports Epicardial Cell Differentiation in Vascular Smooth Muscle Cells through the Activation of the TGFβ Pathway. |
| Q38112029 | Hypoxic pulmonary hypertension of the newborn |
| Q24292883 | Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells |
| Q54775294 | Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. |
| Q39263949 | Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation. |
| Q33885311 | Krüppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cells |
| Q35203387 | Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells |
| Q35358557 | Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis |
| Q38816740 | Mesenchymal stem cells and vascular regeneration. |
| Q56770319 | Mesenchyme homeobox 1 mediates transforming growth factor-β (TGF-β)-induced smooth muscle cell differentiation from mouse mesenchymal progenitors |
| Q48020248 | Multiple lineage-specific roles of Smad4 during neural crest development |
| Q46673025 | PKCδ as a regulator for TGF-β-stimulated connective tissue growth factor production in human hepatocarcinoma (HepG2) cells. |
| Q35681643 | Pericytes, microvasular dysfunction, and chronic rejection. |
| Q24318927 | RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells |
| Q90148577 | RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis |
| Q92520707 | Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT |
| Q24292825 | Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells |
| Q35135052 | Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration |
| Q40165786 | Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells |
| Q34265555 | Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation |
| Q34600308 | Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation |
| Q37890184 | Signaling mechanisms that regulate smooth muscle cell differentiation |
| Q37110500 | Simvastatin Reduces Capsular Fibrosis around Silicone Implants. |
| Q35812561 | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
| Q45250364 | Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts |
| Q35159428 | Smad2 and PEA3 cooperatively regulate transcription of response gene to complement 32 in TGF-β-induced smooth muscle cell differentiation of neural crest cells |
| Q34037390 | Smad2 and myocardin-related transcription factor B cooperatively regulate vascular smooth muscle differentiation from neural crest cells |
| Q34868929 | Smad3-mediated myocardin silencing: a novel mechanism governing the initiation of smooth muscle differentiation |
| Q38596550 | Smooth Muscle Cell Differentiation: Model Systems, Regulatory Mechanisms, and Vascular Diseases |
| Q50714358 | Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors |
| Q55297965 | Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts. |
| Q39668401 | Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation |
| Q42446503 | TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation |
| Q43146931 | TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy |
| Q30440157 | TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
| Q38728066 | TGF-β Stimulates Expression of Chondroitin Polymerizing Factor in Nucleus Pulposus Cells Through the Smad3, RhoA/ROCK1, and MAPK Signaling Pathways. |
| Q34798852 | TGF-β and restenosis revisited: a Smad link |
| Q92667164 | TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation |
| Q37678740 | TGF-β1 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2/Smad3-dependent manner |
| Q84781332 | TGF-β1-induced LPP expression dependant on Rho kinase during differentiation and migration of bone marrow-derived smooth muscle progenitor cells |
| Q37602633 | TGF-β1-induced differentiation of SHED into functional smooth muscle cells. |
| Q34275625 | TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections |
| Q37976673 | TGFβ signaling and cardiovascular diseases |
| Q38876940 | TGFβ-TAZ/SRF signalling regulates vascular smooth muscle cell differentiation |
| Q39484880 | TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2. |
| Q40227380 | The expression of response gene to complement 32 on renal ischemia reperfusion injury in rat. |
| Q53306272 | The mRNA and protein expression of A-kinase anchor proteins 13 in human colorectal cancer. |
| Q37306210 | The role of progenitor cells in the development of intimal hyperplasia |
| Q35098718 | Transcriptional profiling reveals crosstalk between mesenchymal stem cells and endothelial cells promoting prevascularization by reciprocal mechanisms |
| Q90082732 | Transforming growth factor β1 suppresses proinflammatory gene program independent of its regulation on vascular smooth muscle differentiation and autophagy |
| Q35746554 | Transforming growth factor-beta increases the expression of vascular smooth muscle cell markers in human multi-lineage progenitor cells |
| Q35852389 | Transforming growth factor-β and smooth muscle differentiation |
| Q38183143 | Transgelins, cytoskeletal proteins implicated in different aspects of cancer development |
| Q35583950 | p38 MAP kinase inhibitor suppresses transforming growth factor-β2-induced type 1 collagen production in trabecular meshwork cells |
Search more.